As part of its intensive research efforts involving cancer, cardiovascular disease, infectious agents, inflammatory disease and other conditions -- Baylor College of Medicine (BCM) is using the latest optical molecular imaging technology from Carestream Molecular Imaging.
Carestream's KODAK In-Vivo Multispectral Imaging System FX, which combines optical, X-ray and nuclear imaging, allowing researchers to more exactly localize molecular signals in-vivo based on co-registered multi-imaging modalities is installed at BCM's Frensley Center for Imaging Research.
Story Continues Below Advertisement
Top Dollar Paid, Fixed or Mobile. Call our Siemens Specialist for a Quote today -- 212-558-6600 Ext. 250
The center uses imaging to support development of novel agents and other research tools used in the detection and treatment of diseases. Researchers apply the system to a wide variety of imaging techniques that combine optical and x-ray, as well as other modalities such as PET and SPECT isotopes.
The Frensley Center for Imaging Research is led by Dr. Michel E. Mawad, Chair of the Department of Radiology; and Dr. Wei Wang, who is the chemist responsible for design and synthesis of the agents. The Center emphasizes the combination of chemistry and biology research. The mission of the Frensley Center for Imaging Research is to serve the imaging research interests of the basic science and clinical faculty. It also focuses upon industrial collaboration with key device, drug, and imaging partners to bring imaging and therapy advances to the clinic and benefit patients.
About Carestream Molecular Imaging
Carestream Molecular Imaging group, a division of Carestream Health, Inc., develops and markets high performance digital imaging systems, imaging agents, film and accessories under the KODAK brand for the life science research and drug discovery/ development market segments. For more information, visit http://mi.carestreamhealth.com.
KODAK is a trademark of Kodak used under license.